Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a Genetically Determined Personalized Approach in Prescribing Biologically Active Substances in Patients With Elevated Blood Homocysteine Levels, Prospective,Double-blind Randomised Trial.

NCT06264570 is registered in ClinicalTrials.gov with S.LAB (SOLOWAYS) as lead sponsor.

NCT NCT06264570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06264570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a Genetically Determined Personalized Approach in Prescribing Biologically Active Substances in Patients With Elevated Blood Homocysteine Levels, Prospective,Double-blind Randomised Trial.
Lead sponsor
S.LAB (SOLOWAYS)
Phase
Not applicable
Overall status
Recruiting
Start date
October 23, 2023
Completion date
October 30, 2026
Enrollment
111 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperhomocysteinemia